In parallel with our studies, other groups have shown that inhibition of the apelin/APJ pathway improves efficacy of established anti-angiogenic treatments in glioblastoma, and prevents the metastasis associated with anti-angiogenic therapy in breast carcinomas [41, 42]. The gene discussed is APLN; the disease is breast carcinoma.